NCT00655018View on ClinicalTrials.gov

Effect of Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
InflammationFibrosisInsulin Resistance
Interventions
DIETARY_SUPPLEMENT

Vitamin treatment (alpha tocopherol plus ascorbic acid)

alpha tocopherol 600 IU/d plus ascorbic acid 500 mg/d and lifestyle intervention \[hypocaloric Diet(25-30 cal/kg/d) or isocaloric (40-45 cal/kg/d) and physical activity\].

DIETARY_SUPPLEMENT

Placebo

placebo and lifestyle intervention \[hypocaloric Diet(25-30 cal/kg/d) or isocaloric (40-45 cal/kg/d) and physical activity\].

Trial Locations (1)

00165

Dept. Of HepatoGastoEnterology and Nutrition, Liver Unit, Rome

All Listed Sponsors
lead

Bambino Gesù Hospital and Research Institute

OTHER

NCT00655018 - Effect of Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) | Biotech Hunter | Biotech Hunter